Navigation Links
0207 VixOne Nebulizer

Products0207 VixOne Nebulizer
Company Westmed
Item 0207 VixOne Nebulizer
Features 
  • Nebulizer
  • Universal T
  • 7' Kink Resistant Tubing w/Threaded Nut
  • High output nebulizer which delivers medication quickly and efficiently
  • Ideal particle size production (MMAD=2.7 µ) allowing high lung deposition which results in maximum therapeutic effect.
  • Anti-spill Tee design
  • Leak-proof and secure seal with simple 1/4 turn assembly design
  • Very low dead volume (0.7cc)
  • High medication bowl capacity (13cc)
  • Graduated volume (cc) markings on bowl
  • Nebulizes in upright positions or at angles up to 45°
  • Latex Free
  • 50 per case
Description Innovators in Anesthesia and Respiratory Products

Westmed designs, manufacturers and markets leading quality medical devices for Anesthesia and Respiratory professionals. Our mission is to design and manufacture products that enhance the clinician's ability to deliver quality medical care while paying close attention to the bottom line.

Our web site is designed with our customers in mind. The Westmed web site will link you to our company, our people and our products. Like the clinicians we serve, Westmed is dedicated in our pursuit of excellence and enhancing healthcare for all of us.

Aerosol Delivery: From our high efficiency continuous Heart ® Nebulizers to the protection and high concentration of Circulaire ®, Westmed has a nebulizer for all of your needs.
Info Westmed
Customer Service: (800) 724-2328
Web site: http://westmedinc.com/

Related medicine products :

1. 0237 VixOne Infant Nebulizer Kit
2. 0236 VixOne Infant Nebulizer Kit
3. VixOne Infant Extension Set
4. 0209 VixOne Nebulizer
5. 0215 VixOne Nebulizer
6. 0217 VixOne Nebulizer
7. 0210 VixOne Nebulizer
8. 0310 VixOne Nebulizer
9. 0222 VixOne Nebulizer
10. 0311 VixOne Nebulizer
11. 0312 VixOne Nebulizer
Other Medicine News:Health News:PreViser Corporation and MacPractice Announce Cooperation Agreement 2Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 2Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 3Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 4Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 5Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 6Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 7Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 8Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 9Health News:Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 10Health News:Healthcare Realty Trust Announces Fourth Quarter Results 2Health News:Healthcare Realty Trust Announces Fourth Quarter Results 3Health News:Healthcare Realty Trust Announces Fourth Quarter Results 4Health News:Healthcare Realty Trust Announces Fourth Quarter Results 5Health News:Healthcare Realty Trust Announces Fourth Quarter Results 6Health News:Healthcare Realty Trust Announces Fourth Quarter Results 7Health News:Healthcare Realty Trust Announces Fourth Quarter Results 8Health News:Healthcare Realty Trust Announces Fourth Quarter Results 9Health News:Aneurysms in 2nd Generation May Not Come Early 2Health News:Technique May Let More Women Use Tamoxifen 2Health News:Technique May Let More Women Use Tamoxifen 3Health News:Calcium associated with lower risk of cancer in women 2
Breaking Medicine Technology:Within3 Expands into Mobile Applications 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Salt block unexpectedly stretches in Sandia experiments 8980 1Salt block unexpectedly stretches in Sandia experiments 8980 2OMTECs Opening Keynote Emphasizes Increasing Demand for Orthopaedic Procedures 49906 1OMTECs Opening Keynote Emphasizes Increasing Demand for Orthopaedic Procedures 49906 2MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 1MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 2MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 3